// App-Quantinova.ai

12020.0 : Impact of baseline symptom burden as assessed by patient-reported outcomes (PROs) on overall survival (OS) of patients with metastatic cancer.

Researchers

Presenter

  • Atul Batra

Principal Investigators

  • Colleen Ann Cuthbert

  • Andrew Harper

  • Lin Yang

  • Devon J. Boyne

  • Rodrigo Rigo

  • Winson Y. Cheung

Medical Centers

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • University of Calgary, Calgary, AB, Canada

  • Alberta Health Services, Calgary, AB, Canada

  • Tom Baker Cancer Center - University of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved